
Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.
oral solid dose manufacturing, sterile fill/finish, HPAPI manufacturing, advanced therapies (xRNA, viral vectors, microbiome), drug delivery device design, inhalation products, European manufacturing backbone
11 sites worldwide
Directory pages this company appears in, each with the full list of matching manufacturers.